$AMPH
Amphastar Pharmaceuticals, Inc.

2022 Q4 Form 10-Q Financial Statement

#000129718422000056 Filed on November 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $135.0M $120.1M
YoY Change 11.69% 7.07%
Cost Of Revenue $63.86M $61.62M
YoY Change -1.23% 0.99%
Gross Profit $71.17M $58.51M
YoY Change 26.56% 14.32%
Gross Profit Margin 52.71% 48.71%
Selling, General & Admin $16.10M $16.77M
YoY Change 9.55% 7.11%
% of Gross Profit 22.62% 28.66%
Research & Development $14.82M $18.51M
YoY Change 0.71% 72.08%
% of Gross Profit 20.83% 31.64%
Depreciation & Amortization $6.532M $3.421M
YoY Change 13.48% 36.62%
% of Gross Profit 9.18% 5.85%
Operating Expenses $33.34M $35.28M
YoY Change 4.23% 33.57%
Operating Profit $37.83M $23.23M
YoY Change 56.0% -6.22%
Interest Expense $52.00K $566.0K
YoY Change -572.73% 7.4%
% of Operating Profit 0.14% 2.44%
Other Income/Expense, Net $3.376M -$632.0K
YoY Change 15.58% -104.91%
Pretax Income $41.26M $22.60M
YoY Change 51.9% -39.98%
Income Tax $7.290M $6.559M
% Of Pretax Income 17.67% 29.03%
Net Earnings $33.91M $15.87M
YoY Change 71.62% -46.28%
Net Earnings / Revenue 25.12% 13.21%
Basic Earnings Per Share $0.32
Diluted Earnings Per Share $0.66 $0.30
COMMON SHARES
Basic Shares Outstanding 48.33M 49.02M
Diluted Shares Outstanding 52.79M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $175.8M $184.1M
YoY Change 28.6% 60.59%
Cash & Equivalents $156.1M $157.2M
Short-Term Investments $19.66M $26.84M
Other Short-Term Assets $9.998M $8.421M
YoY Change 2.98% -17.36%
Inventory $103.6M $103.3M
Prepaid Expenses
Receivables $88.80M $77.10M
Other Receivables $171.0K $11.36M
Total Short-Term Assets $378.3M $384.2M
YoY Change 18.92% 26.53%
LONG-TERM ASSETS
Property, Plant & Equipment $238.3M $232.7M
YoY Change -2.45% -4.19%
Goodwill $3.126M $2.886M
YoY Change -5.64% -14.77%
Intangibles
YoY Change
Long-Term Investments $2.414M $2.690M
YoY Change -39.42% -35.85%
Other Assets $20.86M $20.55M
YoY Change 25.15% 76.99%
Total Long-Term Assets $363.7M $342.5M
YoY Change 2.9% -1.59%
TOTAL ASSETS
Total Short-Term Assets $378.3M $384.2M
Total Long-Term Assets $363.7M $342.5M
Total Assets $742.0M $726.7M
YoY Change 10.49% 11.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.50M $19.96M
YoY Change -7.71% -7.83%
Accrued Expenses $63.74M $75.83M
YoY Change -5.33% 12.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.046M $1.680M
YoY Change 38.33% -25.53%
Total Short-Term Liabilities $94.86M $102.2M
YoY Change -8.62% 4.29%
LONG-TERM LIABILITIES
Long-Term Debt $76.64M $74.01M
YoY Change -1.97% -2.04%
Other Long-Term Liabilities $14.57M $14.19M
YoY Change -6.95% -4.66%
Total Long-Term Liabilities $91.21M $14.19M
YoY Change -2.8% -4.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $94.86M $102.2M
Total Long-Term Liabilities $91.21M $14.19M
Total Liabilities $213.3M $221.5M
YoY Change -5.61% 0.01%
SHAREHOLDERS EQUITY
Retained Earnings $271.7M $237.8M
YoY Change 50.68% 48.1%
Common Stock $6.000K $6.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $189.5M $171.5M
YoY Change 25.95% 25.11%
Treasury Stock Shares
Shareholders Equity $528.7M $505.2M
YoY Change
Total Liabilities & Shareholders Equity $742.0M $726.7M
YoY Change 10.49% 11.51%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income $33.91M $15.87M
YoY Change 71.62% -46.28%
Depreciation, Depletion And Amortization $6.532M $3.421M
YoY Change 13.48% 36.62%
Cash From Operating Activities $15.23M $20.38M
YoY Change -62.35% 693.11%
INVESTING ACTIVITIES
Capital Expenditures $6.310M -$5.623M
YoY Change -191.74% -22.11%
Acquisitions
YoY Change
Other Investing Activities $6.081M -$9.635M
YoY Change -219.8% -379.28%
Cash From Investing Activities -$229.0K -$15.26M
YoY Change -98.08% 304.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -16.16M -13.93M
YoY Change 85.86% -15.53%
NET CHANGE
Cash From Operating Activities 15.23M 20.38M
Cash From Investing Activities -229.0K -15.26M
Cash From Financing Activities -16.16M -13.93M
Net Change In Cash -1.165M -8.814M
YoY Change -105.89% -50.18%
FREE CASH FLOW
Cash From Operating Activities $15.23M $20.38M
Capital Expenditures $6.310M -$5.623M
Free Cash Flow $8.916M $26.00M
YoY Change -81.16% 165.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Pension Expense
PensionExpense
0
CY2021Q3 us-gaap Pension Expense
PensionExpense
0
us-gaap Pension Expense
PensionExpense
0
CY2022Q3 us-gaap Pension Expense
PensionExpense
0
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91730
dei City Area Code
CityAreaCode
909
dei Local Phone Number
LocalPhoneNumber
980-9484
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7274000
us-gaap Investment Income Interest
InvestmentIncomeInterest
444000
CY2022Q3 us-gaap Interest Expense
InterestExpense
566000
CY2021Q3 us-gaap Interest Expense
InterestExpense
527000
us-gaap Interest Expense
InterestExpense
1318000
us-gaap Interest Expense
InterestExpense
717000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-397000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-632000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1161000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
54307000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
70000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1653000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
36127000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10277000
dei Entity Registrant Name
EntityRegistrantName
Amphastar Pharmaceuticals, Inc.
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2021Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26894000
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
2690000
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001297184
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Shell Company
EntityShellCompany
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Document Transition Report
DocumentTransitionReport
false
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
amph Other Effective Tax Rate Provision Benefit
OtherEffectiveTaxRateProvisionBenefit
0
CY2021Q3 amph Other Effective Tax Rate Provision Benefit
OtherEffectiveTaxRateProvisionBenefit
0
amph Other Effective Tax Rate Provision Benefit
OtherEffectiveTaxRateProvisionBenefit
0
CY2022Q3 amph Other Effective Tax Rate Provision Benefit
OtherEffectiveTaxRateProvisionBenefit
0
dei Document Type
DocumentType
10-Q
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3985000
CY2022Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
37037000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity File Number
EntityFileNumber
001-36509
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
AMPH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39800000
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48331186
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
157244000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126353000
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
235000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
235000
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
26843000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
10320000
CY2022Q3 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
2200000
CY2021Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
2200000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28322000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
77099000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
78804000
CY2022Q3 us-gaap Inventory Net
InventoryNet
103250000
CY2021Q4 us-gaap Inventory Net
InventoryNet
92807000
CY2022Q3 amph Income Tax Refund And Deposits
IncomeTaxRefundAndDeposits
11365000
CY2021Q4 amph Income Tax Refund And Deposits
IncomeTaxRefundAndDeposits
126000
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0702205
dei Entity Address Address Line1
EntityAddressAddressLine1
11570 6th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Rancho Cucamonga
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
us-gaap Depreciation
Depreciation
17615000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5986000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57994848
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48612545
CY2022Q3 us-gaap Assets Current
AssetsCurrent
384222000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
318119000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
232741000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
244244000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
601000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
353000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26456000
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
38870000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20549000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16665000
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
22399000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
22399000
CY2022Q3 us-gaap Assets
Assets
726695000
CY2021Q4 us-gaap Assets
Assets
671529000
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
95796000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
89545000
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1531000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9081000
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1680000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
2202000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3183000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2982000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
102190000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
103810000
CY2022Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
6531000
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
6531000
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
74011000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
74776000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24366000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24703000
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
242000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
534000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14190000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15653000
CY2022Q3 us-gaap Liabilities
Liabilities
221530000
CY2021Q4 us-gaap Liabilities
Liabilities
226007000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6765000
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
171461000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-239000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56440202
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47714912
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
6000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
448741000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
422423000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
237810000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
180337000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9931000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
150479000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
505165000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
445522000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
726695000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
671529000
CY2022Q3 us-gaap Revenues
Revenues
120129000
CY2021Q3 us-gaap Revenues
Revenues
112198000
us-gaap Revenues
Revenues
363964000
us-gaap Revenues
Revenues
316881000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
61619000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
61015000
us-gaap Cost Of Revenue
CostOfRevenue
186272000
us-gaap Cost Of Revenue
CostOfRevenue
173376000
CY2022Q3 us-gaap Gross Profit
GrossProfit
58510000
CY2021Q3 us-gaap Gross Profit
GrossProfit
51183000
us-gaap Gross Profit
GrossProfit
177692000
us-gaap Gross Profit
GrossProfit
143505000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4784000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4745000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16059000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13411000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11984000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10910000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34433000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40813000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18514000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10759000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57535000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43646000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
35282000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
26414000
us-gaap Operating Expenses
OperatingExpenses
108027000
us-gaap Operating Expenses
OperatingExpenses
97870000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23228000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
24769000
us-gaap Operating Income Loss
OperatingIncomeLoss
69665000
us-gaap Operating Income Loss
OperatingIncomeLoss
45635000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12877000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5115000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11342000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22596000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13263000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5692000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11615000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37646000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74780000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
56977000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6559000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6686000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16187000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13436000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
331000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
141000
us-gaap Investment Income Interest
InvestmentIncomeInterest
741000
CY2022Q3 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
16037000
CY2021Q3 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
30960000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
58593000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
43541000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-163000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1120000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
15874000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
30960000
us-gaap Profit Loss
ProfitLoss
57473000
us-gaap Profit Loss
ProfitLoss
43541000
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1412000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1185000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15874000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
29548000
us-gaap Net Income Loss
NetIncomeLoss
57473000
us-gaap Net Income Loss
NetIncomeLoss
42356000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48904000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48022000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48635000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47758000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52788000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50009000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52665000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49693000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15874000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
29548000
us-gaap Net Income Loss
NetIncomeLoss
57473000
us-gaap Net Income Loss
NetIncomeLoss
42356000
CY2021Q3 amph Other Comprehensive Income Loss Reclassification For Amounts Included In Net Income
OtherComprehensiveIncomeLossReclassificationForAmountsIncludedInNetIncome
-362000
amph Other Comprehensive Income Loss Reclassification For Amounts Included In Net Income
OtherComprehensiveIncomeLossReclassificationForAmountsIncludedInNetIncome
-362000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
28202000
CY2021Q3 amph Other Comprehensive Income Loss Attributable To Parent
OtherComprehensiveIncomeLossAttributableToParent
-984000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1222000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-984000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3166000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2194000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1222000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1346000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3166000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2556000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14652000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
445522000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
24253000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-480000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1229000
CY2022Q1 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
6437000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5022000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
479525000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
17346000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1464000
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
6118000
CY2022Q2 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
5783000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4235000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
499307000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15874000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1222000
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
14493000
CY2022Q3 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
1400000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4299000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
505165000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
448723000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
5041000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1921000
CY2021Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1082000
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3783000
CY2021Q1 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
-852000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4834000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
450960000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7767000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
711000
CY2021Q2 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-855000
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5560000
CY2021Q2 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
7247000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5243000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
467223000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
29548000
CY2021Q3 amph Acquisition Of Additional Ownership Interest
AcquisitionOfAdditionalOwnershipInterest
-68718000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21840000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15437000
CY2021Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-1412000
CY2021Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
6094000
CY2021Q3 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
3869000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3920000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
430176000
us-gaap Profit Loss
ProfitLoss
57473000
us-gaap Profit Loss
ProfitLoss
43541000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
52000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-338000
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
13587000
amph Gain Loss On Interest Rate Swaps And Foreign Currency Transactions Net
GainLossOnInterestRateSwapsAndForeignCurrencyTransactionsNet
1124000
amph Gain Loss On Interest Rate Swaps And Foreign Currency Transactions Net
GainLossOnInterestRateSwapsAndForeignCurrencyTransactionsNet
-800000
us-gaap Depreciation
Depreciation
16800000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1088000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
930000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2604000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2471000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1120000
us-gaap Share Based Compensation
ShareBasedCompensation
13556000
us-gaap Share Based Compensation
ShareBasedCompensation
14837000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-5170000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1423000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14166000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12922000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5768000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1342000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1174000
amph Increase Decrease In Income Tax Refund Deposits And Payable
IncreaseDecreaseInIncomeTaxRefundDepositsAndPayable
18789000
amph Increase Decrease In Income Tax Refund Deposits And Payable
IncreaseDecreaseInIncomeTaxRefundDepositsAndPayable
-2832000
amph Operating Lease Right Of Use Assets And Liabilities Net
OperatingLeaseRightOfUseAssetsAndLiabilitiesNet
-2303000
amph Operating Lease Right Of Use Assets And Liabilities Net
OperatingLeaseRightOfUseAssetsAndLiabilitiesNet
-2529000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12924000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4710000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
73955000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
57553000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17724000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20578000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
421000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
30568000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
12459000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15465000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
17423000
amph Payments For Deposits And Other Assets
PaymentsForDepositsAndOtherAssets
142000
amph Payments For Deposits And Other Assets
PaymentsForDepositsAndOtherAssets
1104000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32548000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16718000
amph Payments To Acquire Additional Ownership Interest
PaymentsToAcquireAdditionalOwnershipInterest
53592000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
13620000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10264000
amph Noncash Operating Lease Right Of Use Asset
NoncashOperatingLeaseRightOfUseAsset
2166000
amph Settlement Of Equity Awards
SettlementOfEquityAwards
-839000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
404000
amph Noncash Operating Lease Right Of Use Asset
NoncashOperatingLeaseRightOfUseAsset
11015000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
453000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
107000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1430000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.18
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-175000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30891000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12338000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126588000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94507000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157479000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106845000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3431000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6246000
us-gaap Interest Paid Net
InterestPaidNet
1960000
us-gaap Interest Paid Net
InterestPaidNet
1868000
us-gaap Income Taxes Paid
IncomeTaxesPaid
35166000
us-gaap Income Taxes Paid
IncomeTaxesPaid
5480000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:14pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. The principal accounting estimates include: determination of allowances for credit losses, fair value of financial instruments, allowance for discounts, provision for chargebacks and rebates, provision for product returns, adjustment of inventory to its net realizable values, impairment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">of investments, long-lived and intangible assets and goodwill, accrual for workers’ compensation liabilities, litigation reserves, stock price volatility for share-based compensation expense, valuation allowances for deferred tax assets, and liabilities for uncertain income tax positions.</p>
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1900000
CY2022Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2200000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2000000.0
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-4700000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-900000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2021Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2200000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
amph Revenue Recognition Wholesaler Chargebacks Provision Related To Sales In Period
RevenueRecognitionWholesalerChargebacksProvisionRelatedToSalesInPeriod
151174000
amph Revenue Recognition Wholesaler Chargebacks Credits Issued To Third Parties
RevenueRecognitionWholesalerChargebacksCreditsIssuedToThirdParties
144233000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2021Q4 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
20167000
CY2020Q4 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
20380000
amph Revenue Recognition Wholesaler Chargebacks Provision Related To Sales In Period
RevenueRecognitionWholesalerChargebacksProvisionRelatedToSalesInPeriod
147899000
amph Revenue Recognition Wholesaler Chargebacks Credits Issued To Third Parties
RevenueRecognitionWholesalerChargebacksCreditsIssuedToThirdParties
154143000
CY2022Q3 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
23833000
CY2021Q3 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
17411000
CY2022Q3 amph Product Return Accrual Current
ProductReturnAccrualCurrent
14900000
CY2021Q4 amph Product Return Accrual Current
ProductReturnAccrualCurrent
16000000.0
CY2022Q3 amph Product Return Accrual Non Current
ProductReturnAccrualNonCurrent
4800000
CY2021Q4 amph Product Return Accrual Non Current
ProductReturnAccrualNonCurrent
5700000
amph Product Return Rate Percentage
ProductReturnRatePercentage
0.014
amph Product Return Rate Percentage
ProductReturnRatePercentage
0.017
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15874000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
29548000
us-gaap Net Income Loss
NetIncomeLoss
57473000
us-gaap Net Income Loss
NetIncomeLoss
42356000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48904000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48022000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48635000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47758000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3884000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
1987000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
4030000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
1935000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52788000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50009000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52665000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49693000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
35282000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
26414000
CY2022Q3 us-gaap Noncurrent Assets
NoncurrentAssets
259798000
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
271491000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q3 us-gaap Revenues
Revenues
120129000
CY2021Q3 us-gaap Revenues
Revenues
112198000
us-gaap Revenues
Revenues
363964000
us-gaap Revenues
Revenues
316881000
CY2022Q3 us-gaap Gross Profit
GrossProfit
58510000
CY2021Q3 us-gaap Gross Profit
GrossProfit
51183000
us-gaap Gross Profit
GrossProfit
177692000
us-gaap Gross Profit
GrossProfit
143505000
us-gaap Operating Expenses
OperatingExpenses
108027000
us-gaap Operating Expenses
OperatingExpenses
97870000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23228000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
24769000
us-gaap Operating Income Loss
OperatingIncomeLoss
69665000
us-gaap Operating Income Loss
OperatingIncomeLoss
45635000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-632000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12877000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5115000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11342000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22596000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37646000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74780000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
56977000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3421000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2504000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9159000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7626000
CY2022Q3 us-gaap Revenues
Revenues
120129000
CY2021Q3 us-gaap Revenues
Revenues
112198000
us-gaap Revenues
Revenues
363964000
us-gaap Revenues
Revenues
316881000
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1680000
CY2022Q3 us-gaap Contractual Obligation
ContractualObligation
77342000
CY2021Q4 us-gaap Contractual Obligation
ContractualObligation
78583000
CY2021Q4 amph Accrued Loss On Firm Purchase Commitments
AccruedLossOnFirmPurchaseCommitments
7133000
CY2022Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
23172000
CY2022Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
83000
CY2022Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
23089000
CY2021Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
6992000
CY2021Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
8000
CY2021Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
6984000
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10832000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5906000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4926000
CY2022Q3 amph Indefinite Lived Intangible Assets Including Goodwill Gross
IndefiniteLivedIntangibleAssetsIncludingGoodwillGross
32111000
CY2022Q3 amph Indefinite Lived Intangible Assets Including Goodwill Net
IndefiniteLivedIntangibleAssetsIncludingGoodwillNet
32111000
CY2022Q3 amph Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
42943000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5906000
CY2022Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
37037000
CY2021 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P12Y
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12471000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6139000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6332000
CY2021Q4 amph Indefinite Lived Intangible Assets Including Goodwill Gross
IndefiniteLivedIntangibleAssetsIncludingGoodwillGross
32538000
CY2021Q4 amph Indefinite Lived Intangible Assets Including Goodwill Net
IndefiniteLivedIntangibleAssetsIncludingGoodwillNet
32538000
CY2021Q4 amph Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
45009000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6139000
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
38870000
CY2021Q4 us-gaap Goodwill
Goodwill
3313000
CY2020Q4 us-gaap Goodwill
Goodwill
3940000
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-427000
CY2021 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-253000
CY2022Q3 us-gaap Goodwill
Goodwill
2886000
CY2021Q4 us-gaap Goodwill
Goodwill
3313000
CY2022Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
47082000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
41853000
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
38560000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
33298000
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17608000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17656000
CY2022Q3 us-gaap Inventory Net
InventoryNet
103250000
CY2021Q4 us-gaap Inventory Net
InventoryNet
92807000
CY2022Q3 us-gaap Inventory Write Down
InventoryWriteDown
5500000
us-gaap Inventory Write Down
InventoryWriteDown
14100000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
23256000
CY2022Q3 amph Product Return Accrual Current
ProductReturnAccrualCurrent
14853000
CY2021Q4 amph Product Return Accrual Current
ProductReturnAccrualCurrent
16028000
CY2022Q3 amph Accrued Loss On Firm Purchase Commitments
AccruedLossOnFirmPurchaseCommitments
7450000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
445936000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
443863000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
213195000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
199619000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
232741000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
244244000
CY2022Q3 amph Accrued Customer Fees And Rebates
AccruedCustomerFeesAndRebates
13972000
CY2021Q4 amph Accrued Customer Fees And Rebates
AccruedCustomerFeesAndRebates
12121000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26872000
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
621000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
398000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12686000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8793000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75833000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
67331000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
19963000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22214000
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
95796000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
89545000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
2202000
CY2022Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
1651000
CY2021Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
1605000
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
74011000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
74776000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22596000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37646000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74780000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
56977000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6559000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6686000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16187000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13436000
CY2022Q3 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
16037000
CY2021Q3 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
30960000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
58593000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
43541000
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.290
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.178
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.216
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.236
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.023
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.427
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.414
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.410
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.421
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.029
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.011
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.012
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8455721
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.67
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
792441
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
34.35
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1156664
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
14.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
91251
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
19.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
5614
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
13.79
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7994633
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.62
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y2M1D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
88639000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5614323
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.65
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10M9D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
69885000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7788485
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
17.45
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y25D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
87242000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1421000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.40
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.62
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2176000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
20131000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5292000
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1483000
CY2021Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3953000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18402000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12122000
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
167000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
112000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8157000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8162000
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2848934
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.95
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
792441
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1169814
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
6.97
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
91251
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
8.41
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2380310
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
9.48
CY2022Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
3500000
CY2021Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
3500000
CY2022Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
3600000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
2300000
CY2021Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
3600000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4299000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3919000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13556000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14837000
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2022Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1600000
CY2021Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1500000
CY2022Q3 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.025
CY2021Q4 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.010
CY2022Q3 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2500000
CY2021Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2600000

Files In Submission

Name View Source Status
0001297184-22-000056-index-headers.html Edgar Link pending
0001297184-22-000056-index.html Edgar Link pending
0001297184-22-000056.txt Edgar Link pending
0001297184-22-000056-xbrl.zip Edgar Link pending
amph-20220930.xsd Edgar Link pending
amph-20220930x10q.htm Edgar Link pending
amph-20220930xex10d1.htm Edgar Link pending
amph-20220930xex31d1.htm Edgar Link pending
amph-20220930xex31d2.htm Edgar Link pending
amph-20220930xex32d1.htm Edgar Link pending
amph-20220930xex32d2.htm Edgar Link pending
amph-20220930_cal.xml Edgar Link unprocessable
amph-20220930_def.xml Edgar Link unprocessable
amph-20220930x10q_htm.xml Edgar Link completed
amph-20220930_lab.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
amph-20220930_pre.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending